A team of researchers from the Robert Koch Institute in Berlin and the Max Planck Institute for the Science of Human History present a novel method for the rapid estimation of incidence trajectories from serially sampled ...
Oct 14, 2021
0
70
The COVID-19 pandemic is a dramatic demonstration of evolution in action. Evolutionary theory explains much of what has already happened, predicts what will happen in the future and suggests which management strategies are ...
Aug 23, 2021
0
66
Although the development and increasingly widespread availability of effective and safe vaccines provides the greatest hope for the future recovery from the increasingly devastating COVID-19 pandemic, genomic surveillance ...
Aug 18, 2021
0
117
An analysis of the DNA of thousands of people who have been infected with the coronavirus, SARS-CoV-2, and shown a positive test for the disease it causes, COVID-19, shows that they have several DNA characteristics in common. ...
Aug 16, 2021
0
418
Viral mutations during the COVID-19 pandemic could cause the SARS-CoV-2 virus to become more dangerous. A new study published in Genetic Epidemiology has examined the genetic code of SARS-CoV-2 viruses that have infected ...
Jun 23, 2021
0
2
Viral genome sequencing of wastewater can provide an early warning system of emerging SARS-CoV-2 variants that is independent of investigations of identified clinical cases, according to a new study published in mSystems, ...
Jun 15, 2021
0
1
A University of Alberta virology lab has uncovered how an oral antiviral drug works to attack the SARS-CoV-2 virus, in findings published May 10 in the Journal of Biological Chemistry.
May 11, 2021
0
5
A University of Manchester team has applied new techniques to detect and track the transmission of COVID-19 in hospitals.
Mar 30, 2021
0
0
Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as liver cirrhosis and liver ...
Feb 4, 2021
0
7
Remdesivir is the first drug against COVID-19 to be conditionally approved in Europe and the United States. The drug is designed to suppress the rapid replication of the SARS-CoV-2 virus in human cells by blocking the viral ...
Jan 13, 2021
0
137
